MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter (T46.905A)

HealthDay 09 July at 03.42 PM

Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.Ildiko Lingvay, M.D., from the University of Texas Southwestern Medical Center in Da

HealthDay 28 June at 03.03 PM

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among patients with moderate-to-severe obstructive sleep apnea (OSA) and obesity, according to a study published online June 21 in the Journal of the American College of Cardiology.Ali Aminian,

HealthDay 27 June at 03.03 PM

hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis

For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology.Brittany N. Weber, M.D., Ph.D.,